Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dooley

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Contemporary Clinical Trials|September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adultsJ Furin, E Alirol, E Allen, et al.
Journal of the American Heart Association|October 18, 2024
Optimal Instruments for Measurement of Dietary Intake, Physical Activity, and Sleep Among Adults in Population-Based Studies: Report of a National Heart, Lung, and Blood Institute WorkshopGabriel Anaya, Kelley Pettee Gabriel, Marie-Pierre St-Onge, et al.
The New England Journal of Medicine|May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Circulation|December 20, 2022
Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-AnalysisAmanda E Paluch, Shivangi Bajpai, Marcel Ballin, et al.
The Lancet. Infectious Diseases|September 29, 2024
Advancing the chemotherapy of tuberculous meningitis: a consensus viewSean Wasserman, Joseph Donovan, Evelyne Kestelyn, et al.
The Lancet. Infectious Diseases|August 21, 2025
A clinical practice guideline for tuberculous meningitisJoseph Donovan, Fiona V Cresswell, Elizabeth W Tucker, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 2, 2023
Standards for clinical trials for treating TBP du Cros, J Greig, J-W C Alffenaar, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Contemporary Clinical Trials|September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adultsJ Furin, E Alirol, E Allen, et al.
Journal of the American Heart Association|October 18, 2024
Optimal Instruments for Measurement of Dietary Intake, Physical Activity, and Sleep Among Adults in Population-Based Studies: Report of a National Heart, Lung, and Blood Institute WorkshopGabriel Anaya, Kelley Pettee Gabriel, Marie-Pierre St-Onge, et al.
The New England Journal of Medicine|May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Circulation|December 20, 2022
Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-AnalysisAmanda E Paluch, Shivangi Bajpai, Marcel Ballin, et al.
The Lancet. Infectious Diseases|September 29, 2024
Advancing the chemotherapy of tuberculous meningitis: a consensus viewSean Wasserman, Joseph Donovan, Evelyne Kestelyn, et al.
The Lancet. Infectious Diseases|August 21, 2025
A clinical practice guideline for tuberculous meningitisJoseph Donovan, Fiona V Cresswell, Elizabeth W Tucker, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 2, 2023
Standards for clinical trials for treating TBP du Cros, J Greig, J-W C Alffenaar, et al.
Pageof 27